Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
Slika profila

Anita Bosak

3072

Anita

Bosak

dr. sc.

Naziv Uloga Akcije
Razvoj bioaktivnih molekula za tretman neurodegenerativnih bolesti voditelj
Procjena učinkovitosti i toksičnosti biološki aktivnih tvari suradnik
Analiza interakcija butirilkolinesteraze s novim inhibitorima i reaktivatorima suradnik
Naziv Akcije
Aleksandrina Vodolšak Sinteza i biološka evaluacija heterocikličkih karbamata kao inhibitora humanih kolinesteraza / Bosak, Anita (mentor); Matošević, Ana (neposredni voditelj). Zagreb, Prirodoslovno-matematički fakultet, Zagreb, . 2023
Matošević, Ana Dizajn, sinteza i biološka evaluacija biskarbamata kao potencijalnih selektivnih inhibitora butirilkolinesteraze / Bosak, Anita (mentor); Zagreb, Prirodoslovno-matematički fakultet, Zagreb, . 2023
Matošević, Ana; Bosak, Anita Design, synthesis and biological evaluation of carbamates as cholinesterases inhibitors in the treatment of Alzheimer`s disease // 9th Conference of Young Chemists of Serbia: Book of Abstracts. Beograd: Serbian Chemical Society and Serbian Young Chemists’ Club, 2023. str. 13-13
Bartolić, Marija; Šušak, Petra; Arežina, Marko; Laučan, Matea; Ramić, Alma; Hrenar, Tomica; Primožič, Ines; Bosak, Anita Quinuclidinium Based O-Alkyl Oximes as Potential Anticholinesterase Agents in Symptomatic Treatment of Alzheimer's Disease // 10th EFMC Young Medicinal Chemists' Symposium - Book of Abstracts. Louvain-la-Neuve, Wallonia, Belgium: European Federation for Medicinal chemistry and Chemical biology (EFMC), 2023. str. 111-111
Novaković, Irena; Matošević, Ana; Milovanović, Vukan; Bartolić, Marija; Opsenica, Dejan; Sladić, Dušan; Bosak, Anita 1,4-benzoquinones as potent agents for Alzheimer`s disease treatment // IX EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry: Book of Abstracts. Louvain-la-Neuve, Wallonia, Belgium: European Federation for Medicinal chemistry and Chemical biology (EFMC), 2023. str. 270-270
Bartolić, Marija; Bosak, Anita Multiple Problems, One Solution: Multi-Target Directed Ligands as the Future Treatment for Alzheimer's Disease // 7th Mini Symposium of Section of Medicinal and Pharmaceutical Chemistry: Book of Abstracts. Zagreb: HKD - sekcija za medicinsku i farmaceutsku kemiju, 2023. str. 3-3
Matošević, Ana; Bosak, Anita; Zandona, Antonio; Maraković, Nikola Carbamates as potential new drugs in the treatment of Alzheimer`s disease // IX EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry: Book of Abstracts. Louvain-la-Neuve, Wallonia, Belgium: European Federation for Medicinal chemistry and Chemical biology (EFMC), 2023. str. 253-253
Matošević, Ana ; Opsenica, Dejan ; Spasić, Marta ; Maraković, Nikola ; Zandona, Antonio ; Žunec, Suzana ; Bartolić, Marija ; Kovarik, Zrinka ; Bosak, Anita Evaluation of 4-aminoquinoline derivatives with an n-octylamino spacer as potential multi-targeting ligands for the treatment of Alzheimer's disease // Chemico-biological interactions, 382 (2023), 110620, 13. doi: 10.1016/j.cbi.2023.110620
Bosak, Anita; Matošević, Ana; Opsenica, Dejan M.; Maraković, Nikola; Zandona, Antonio; Žunec, Suzana; Bartolić, Marija; Šegan, Sandra N-octylamino derivatives of 4-aminoquinoline as possible multifuctional agents for Alzheimer`s disease treatment // IX EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry: Book of Abstracts. Louvain-la-Neuve, Wallonia, Belgium: European Federation for Medicinal chemistry and Chemical biology (EFMC), 2023. str. 117-117
Bartolić, Marija; Šušak, Petra; Arežina, Marko; Laučan, Matea; Ramić, Alma; Hrenar, Tomica; Primožič, Ines; Bosak, Anita Quinuclidinium Based O-Alkyl Oximes as Potential Anticholinesterase Agents in Symptomatic Treatment of Alzheimer's Disease // IX EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry: Book of Abstracts. Louvain-la-Neuve, Wallonia, Belgium: European Federation for Medicinal chemistry and Chemical biology (EFMC), 2023. str. 106-106
nije evidentirano
nije evidentirano